Raw-materials supplier Granules India has ambitions to become a vertically-integrated oncology player as it exits joint ventures in the ibuprofen manufacturing and contract research and manufacturing services arenas.
Granules Eyes Oncology After Exiting Ventures
Plans To Sit On Cash from Omnichem And Biocause Exits
Granules India has ambitions to become a vertically integrated player in cancer therapies after the company ended joint ventures for contract research and manufacturing services as well as for making bulk ibuprofen.
